The Extraordinary General Meeting of shareholders of the company Ultimovacs ASA, held on 09/01/2025,
decided to change its company name to Zelluna ASA
Therefore, as of 04/03/2025, the product name and the symbol of the ordinary shares will be modified.

Identification

Symbole
ZLNA
Code ISIN
NO0010851603
Code LEI
254900B4VALJZR9TL744
Exchange / Market
Oslo Børs
Trading location
Oslo
ICB
20103010 Biotechnology
Site internet
www.ultimovacs.com

Operation

Date de l'IPO
mar 04/03/2025
Type d'IPO
Merger
Private placement

Company profile

Zelluna is a biotech company whose mission is to eliminate solid cancers by unleashing the most powerful elements of the immune system through pioneering the development of T cell receptor-guided natural killer cell therapies.

Source: Zelluna ASA - Last Update: 01/04/2025